Primary information |
---|
sequence ID | Seq_7273 |
Peptide sequence | SLAELGGHLDQQVEEFRR |
CancerPDF_ID | CancerPDF_ID350, CancerPDF_ID1384, CancerPDF_ID2615, |
PMID | 19795908,21136997,21136997 |
Protein Name | Apolipoprotein A-IV,Apolipoprotein A-IV,Apolipoprotein A-IV |
UniprotKB Entry Name | APOA4_HUMAN,APOA4_HUMAN,APOA4_HUMAN |
Fluid | Plasma,Serum,Plasma |
M/Z | 695.35,2083.04467,2083.0447 |
Charge | 3,1,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS |
Labelled/Label Free | Labelled,Label Free,Label Free |
FDR | less than 7%,NA,NA |
CancerPDF_ID | CancerPDF_ID350, CancerPDF_ID1384, CancerPDF_ID2615, |
p-Value | NA,5.53E-04,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
Length | 18,18,18 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal |
Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "40 normal, 28 patients",30 patients and 30 healthy controls,27 healthy individuals |
Regulation | NA,Differentially expressed between cancer vs normal,NA |
Validation | NA,Leave One out Cross validation,Leave One out Cross validation |
Sensitivity | NA,0.898,NA |
Specificity | NA,0.946,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |